Latest Articles

Publication Date
All News Scientific
NICE Approves First-Ever Daily Pill for Endometriosis Treatment - geneonline

NICE Approves First-Ever Daily Pill for Endometriosis Treatment geneonline

Published: March 20, 2025, 9:03 a.m.
Read Full Article
NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData - Express Pharma

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData Express Pharma

Published: March 20, 2025, 8:30 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.
Read Full Article
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.
Read Full Article
NHS approval of endometriosis therapy Ryeqo enhances patient care - The Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care The Hippocratic Post

Published: March 19, 2025, 12:01 p.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Read Full Article
Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical - openPR

Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical openPR

Published: March 18, 2025, 7:40 p.m.
Read Full Article
NEWS: First Daily Pill Approved For Endometriosis - Practice Business

NEWS: First Daily Pill Approved For Endometriosis Practice Business

Published: March 18, 2025, 6:33 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!